| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2024 | AHCO Adapthealth Corp. | Williams David Solomon III60 | Director | Sell | 8,509 | $10.55 | $89,777.73 | -8.7% | -9.8% | -14.3% | |
| Aug 28, 2024 | TLSI Trisalus Life Sciences, Inc. | Martin George Kelly | - | Sell | 9 | $5.50 | $49.50 | - | -13.4% | +2.4% | |
| Aug 28, 2024 | BSX Boston Scientific Corp | Fitzgerald Joseph Michael51 | EVP &Group Pres, Cardiology | Sell | 14,132 | $80.00 | $1,130,560.00 | -7.4% | +13.4% | +33.0% | |
| Aug 28, 2024 | ZOMDF Zomedica Corp. | Powers Johnny D | Director | Buy | 100,000 | $0.13 | $12,900.00 | +4.5% | - | - | |
| Aug 28, 2024 | PODD Insulet Corp | Field Mark N | SVP &Chief Technology Officer | Sell | 1,387 | $203.00 | $281,561.00 | -10.9% | +30.3% | +65.2% | |
| Aug 28, 2024 | LNSR Lensar, Inc. | Winer Gary M53 | Director | Buy | 2,302 | $4.51 | $10,373.16 | +1.0% | +59.3% | +160.2% | |
| Aug 27, 2024 | SYK Stryker Corp | Menon Viju | Group President | Sell | 600 | $355.00 | $213,000.00 | -6.2% | +7.4% | +9.7% | |
| Aug 27, 2024 | LAB Standard Biotools Inc. | Casdin Partners Master Fund, L.P.53 | Director, 10% Owner | Buy | 250,000 | $2.19 | $546,750.00 | +0.5% | -25.7% | -41.3% | |
| Aug 27, 2024 | TMDX Transmedics Group, Inc. | Corcoran Nicholas | See Remarks | Sell | 10,000 | $176.02 | $1,760,200.00 | -32.1% | -55.4% | -33.3% | |
| Aug 27, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 8,881 | $0.94 | $8,375.05 | - | -33.7% | -12.6% | |
| Aug 26, 2024 | MXCT Maxcyte, Inc. | Johnston John Joseph75 | Director | Sell | 3,000 | $4.28 | $12,840.00 | -2.1% | -16.6% | -67.9% | |
| Aug 26, 2024 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 3,167 | $26.55 | $84,095.88 | -1.9% | +7.1% | +66.0% | |
| Aug 26, 2024 | BSX Boston Scientific Corp | Butcher Arthur C46 | EVP&Grp Pres, Medsurg &Apac | Sell | 14,012 | $79.25 | $1,110,515.46 | -56.5% | +12.3% | +33.9% | |
| Aug 26, 2024 | ATR Aptargroup, Inc. | Kuhn Robert50 | EVP &CFO | Sell | 1,000 | $151.29 | $151,287.00 | -1.5% | +14.9% | -7.0% | |
| Aug 26, 2024 | ISRG Intuitive Surgical Inc | Desantis Robert49 | EVP &Chief Strategy &Corp Op | Sell | 396 | $486.88 | $192,804.48 | -3.5% | +12.0% | -1.0% | |
| Aug 26, 2024 | ATR Aptargroup, Inc. | Vinczeller Shiela51 | Chief Human Resources Officer | Sell | 1,660 | $151.15 | $250,904.68 | -6.8% | +14.9% | -7.0% | |
| Aug 26, 2024 | LAB Standard Biotools Inc. | Casdin Partners Master Fund, L.P.53 | Director, 10% Owner | Buy | 750,000 | $2.06 | $1,546,237.01 | +0.5% | -25.3% | -40.6% | |
| Aug 23, 2024 | ATR Aptargroup, Inc. | Kuhn Robert50 | EVP &CFO | Sell | 49,463 | $149.97 | $7,418,095.15 | -27.4% | +12.9% | -6.0% | |
| Aug 23, 2024 | NXGL Nexgel, Inc. | Zeldis Jerome B | Director | Buy | 10,000 | $2.50 | $25,000.00 | +10.7% | +25.8% | -10.8% | |
| Aug 23, 2024 | NXGL Nexgel, Inc. | Glassman Steven Mark48 | Director | Buy | 10,000 | $2.50 | $25,000.00 | +7.4% | +25.8% | -10.8% | |
| Aug 23, 2024 | NXGL Nexgel, Inc. | Drapczuk Adam E III62 | Chief Financial Officer | Buy | 10,000 | $2.50 | $25,000.00 | +21.1% | +25.8% | -10.8% | |
| Aug 23, 2024 | NXGL Nexgel, Inc. | Henry Scott Robert72 | Director | Buy | 10,000 | $2.50 | $25,000.00 | +7.4% | +25.8% | -10.8% | |
| Aug 23, 2024 | NXGL Nexgel, Inc. | Stein John Nachum62 | Director | Buy | 10,000 | $2.50 | $25,000.00 | +2.2% | +25.8% | -10.8% | |
| Aug 23, 2024 | ATEC Alphatec Holdings, Inc. | Bakst Evan51 | Director | Buy | 35,000 | $5.76 | $201,600.00 | +233.3% | +77.9% | +181.1% | |
| Aug 23, 2024 | UFPT Ufp Technologies Inc | Lataille Ronald J59 | Chief Financial Officer | Sell | 2,392 | $329.04 | $787,066.70 | -1.5% | -9.5% | -33.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.